问答：临床医生和患者需要了解的脱发新药管线
FAQ: Everything Clinicians (and Their Patients) Want to Know About the Hair Loss Pipeline
Dermatology Times 以问答形式梳理称，三类实验性脱发机制数十年来首次进入后期试验，2026年的管线话题集中在更常见的雄激素性脱发（AGA），而非此前的斑秃。当下正值全国斑秃意识月，脱发成为就诊热点话题。
Feature|Articles|September 24, 2026
Three experimental hair loss mechanisms are moving through late-stage trials for the first time in decades, and the data are worth knowing before patients ask.
September marks National Alopecia Areata Awareness Month, as designated by the National Alopecia Areata Foundation, making hair loss a common topic in visits this time of year.¹ Much of that public conversation centers on alopecia areata, but 2026's most notable pipeline news sits in a different, more common form of hair loss: androgenetic alopecia (AGA).
Related to this article
来源：Dermatology Times 皮肤科时报 · dermatologytimes.com